Ingram Douglas S (CIK 0001190644)

Latest company ownership

Shares held
390,307
Last filed at
Nov 6, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4
Shares held
25,000
Last filed at
Jul 21, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
ECRO - ECC Capital CORP
Role: Director
Shares held
20,000
Last filed at
Feb 23, 2005
Confidence Score
50.0
2025Q4
Confidence Score History
2005Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 3, 2023 Nov 6, 2023 Sarepta Therapeutics, Inc. CEO Buy 95.0 +25,225 6.91% ✗ $2M
Nov 17, 2021 Nov 17, 2021 Sarepta Therapeutics, Inc. CEO Buy 95.0 +25,026 7.36% ✗ $2M
Jun 26, 2021 Jun 28, 2021 Sarepta Therapeutics, Inc. CEO Sell 37.5 -17,812 -4.98% ✗ $1.4M
Dec 31, 2020 Jan 4, 2021 Sarepta Therapeutics, Inc. CEO Sell 36.3 -37,144 -9.40% ✗ $6.3M
Jul 20, 2020 Jul 21, 2020 Relay Therapeutics, Inc. Director Buy 97.5 +25,000 100.00% ✗ $500K
Dec 31, 2019 Jan 3, 2020 Sarepta Therapeutics, Inc. CEO Sell 37.5 -37,185 -8.60% ✗ $4.8M
Aug 12, 2019 Aug 12, 2019 Sarepta Therapeutics, Inc. CEO Buy 92.5 +16,252 3.91% ✗ $2M
Oct 30, 2018 Oct 30, 2018 Sarepta Therapeutics, Inc. CEO Buy 92.5 +16,695 4.18% ✗ $2M
Aug 15, 2018 Aug 16, 2018 Sarepta Therapeutics, Inc. CEO Buy 92.5 +16,000 4.17% ✗ $2M
Jun 26, 2018 Jun 27, 2018 Sarepta Therapeutics, Inc. CEO Sell 36.3 -36,946 -8.79% ✗ $5M
Nov 8, 2017 Nov 13, 2017 Sarepta Therapeutics, Inc. CEO Buy 95.0 +38,138 9.98% ✗ $2M
Jul 27, 2017 Jul 28, 2017 Sarepta Therapeutics, Inc. CEO Buy 100.0 +47,058 14.05% ✗ $2M
Feb 18, 2005 Feb 23, 2005 ECC Capital CORP Director Buy 95.0 +29,629 100.00% ✗ $200K